EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 120 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.42 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $227,000 | -5.8% | 3,806 | +24.4% | 0.21% | -3.7% |
| Q2 2017 | $241,000 | -4.7% | 3,060 | +0.3% | 0.22% | -12.6% |
| Q1 2017 | $253,000 | -18.4% | 3,050 | -21.9% | 0.25% | -24.5% |
| Q4 2016 | $310,000 | +2.6% | 3,905 | -9.4% | 0.33% | +9.7% |
| Q3 2016 | $302,000 | +38.5% | 4,310 | -20.0% | 0.30% | +150.4% |
| Q1 2016 | $218,000 | -54.1% | 5,388 | +0.6% | 0.12% | -49.1% |
| Q4 2015 | $475,000 | +19.6% | 5,358 | 0.0% | 0.23% | +9.3% |
| Q3 2015 | $397,000 | -2.9% | 5,358 | +6.1% | 0.21% | +17.6% |
| Q2 2015 | $409,000 | -18.2% | 5,052 | -57.6% | 0.18% | -17.6% |
| Q1 2015 | $500,000 | – | 11,925 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hudson Executive Capital LP | 1,323,794 | $79,534,000 | 3.54% |
| Park West Asset Management LLC | 1,171,880 | $70,406,000 | 2.96% |
| Matarin Capital Management, LLC | 170,008 | $10,214,000 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 140,014 | $8,412,000 | 0.82% |
| Capital Impact Advisors, LLC | 33,725 | $2,026,000 | 0.71% |
| U S GLOBAL INVESTORS INC | 18,800 | $1,130,000 | 0.51% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 187,989 | $11,294,000 | 0.37% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,442,000 | 0.34% |
| GLOBEFLEX CAPITAL L P | 18,751 | $1,127,000 | 0.21% |
| Foundry Partners, LLC | 70,357 | $4,227,000 | 0.16% |